Literature DB >> 28976087

Noninvasive diagnosis in dermatology.

Julia Welzel1, Sandra Schuh1.   

Abstract

In addition to dermoscopy, there are other imaging and biophysical methods for the noninvasive diagnosis of skin lesions. Confocal laser microscopy allows for high-resolution imaging of the epidermis and upper dermis. It is particularly suitable in the differential diagnosis of melanocytic lesions. Optical coherence tomography (OCT) has a lower resolution compared to confocal laser microscopy but a greater depth of penetration. It is primarily used for imaging epithelial skin cancer, especially in the context of monitoring the effectiveness of nonsurgical therapies. Electrical impedance spectroscopy does not yield cutaneous images but rather provides a score based on the cellular irregularity of the skin. Multispectral analysis involves illumination of the skin with different wavelengths and likewise results in the computation of a score. Both methods are used in the differentiation of dysplastic nevi from melanoma. Other diagnostic imaging and biophysical methods are currently still in the developmental stages. By increasing the sensitivity and specificity of clinical and dermoscopic findings, the aforementioned methods bring about an improvement in noninvasive diagnosis. They allow for skin lesions to be monitored over time and therapeutic effects to be quantified. Finally, they facilitate early diagnosis of skin cancer, and help avoid unnecessary surgery of benign lesions.
© 2017 Deutsche Dermatologische Gesellschaft (DDG). Published by John Wiley & Sons Ltd.

Entities:  

Mesh:

Year:  2017        PMID: 28976087     DOI: 10.1111/ddg.13347

Source DB:  PubMed          Journal:  J Dtsch Dermatol Ges        ISSN: 1610-0379            Impact factor:   5.584


  9 in total

1.  [Failure to perform dermoscopy in melanoma-suspicious skin lesions in dermatological practice : Possible medical liability].

Authors:  L Niebergall; J Meyer; K Kols; P Elsner
Journal:  Hautarzt       Date:  2018-04       Impact factor: 0.751

2.  Hyperspectral and multispectral image processing for gross-level tumor detection in skin lesions: a systematic review.

Authors:  Eleni Aloupogianni; Masahiro Ishikawa; Naoki Kobayashi; Takashi Obi
Journal:  J Biomed Opt       Date:  2022-06       Impact factor: 3.758

3.  Screening for malignant melanoma-a critical assessment in historical perspective.

Authors:  Wolfgang Weyers
Journal:  Dermatol Pract Concept       Date:  2018-04-30

Review 4.  Ultrasound and Infrared-Based Imaging Modalities for Diagnosis and Management of Cutaneous Diseases.

Authors:  Sheliza Halani; F Stuart Foster; Maksym Breslavets; Neil H Shear
Journal:  Front Med (Lausanne)       Date:  2018-04-25

5.  Multispectral near infrared absorption imaging for histology of skin cancer.

Authors:  Alexander Spreinat; Gabriele Selvaggio; Luise Erpenbeck; Sebastian Kruss
Journal:  J Biophotonics       Date:  2019-11-05       Impact factor: 3.207

6.  Line-Field Confocal Optical Coherence Tomography: A New Tool for the Differentiation between Nevi and Melanomas?

Authors:  Sandra Schuh; Cristel Ruini; Maria Katharina Elisabeth Perwein; Fabia Daxenberger; Charlotte Gust; Elke Christina Sattler; Julia Welzel
Journal:  Cancers (Basel)       Date:  2022-02-23       Impact factor: 6.639

7.  Diagnostic Accuracy of Electrical Impedance Spectroscopy in Non-melanoma Skin Cancer.

Authors:  Esra Sarac; Andreas Meiwes; Thomas Eigentler; Stephan Forchhammer; Lukas Kofler; Hans-Martin Häfner; Claus Garbe
Journal:  Acta Derm Venereol       Date:  2020-11-23       Impact factor: 3.875

8.  A Scoping Review of Non-invasive Imaging Modalities in Dermatological Disease: Potential Novel Biomarkers in Hidradenitis Suppurativa.

Authors:  David Grand; Kristina Navrazhina; John W Frew
Journal:  Front Med (Lausanne)       Date:  2019-11-06

9.  To resume noninvasive imaging detection safely after peak period of COVID-19: Experiences from Wuhan China.

Authors:  Xiangjie An; Zexing Song; Yaoying Gao; Juan Tao; Jing Yang
Journal:  Dermatol Ther       Date:  2020-06-04       Impact factor: 3.858

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.